Related Experiment Videos

High validity of cardiomyopathy diagnoses in western Sweden (1989-2009)

Carmen Basic1, Annika Rosengren1, Sandra Lindström2

  • 1Section of Emergency and Cardiovascular Medicine, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.

ESC Heart Failure
|October 13, 2017
PubMed

Insights

Hospitalizations for cardiomyopathy have increased significantly in Sweden. This study validates these diagnoses, confirming a real rise in cardiomyopathy cases, not just improved detection methods.

Area of Science:

  • Cardiology
  • Epidemiology
  • Medical Diagnostics

Background:

  • Hospital discharges for cardiomyopathy in Sweden have more than doubled since 1987.
  • The study aims to validate these diagnoses to determine if the increase is real or due to improved diagnostic methods.

Purpose of the Study:

  • To validate cardiomyopathy diagnoses in Sweden between 1989 and 2009.
  • To ascertain if the rise in diagnoses reflects an actual increase in disease prevalence.

Main Methods:

  • Retrospective analysis of patient records from three hospitals in Västra Götaland, Sweden (1989-2009).
  • Validation of diagnoses using European Society of Cardiology 2008 criteria.
  • Inclusion of 611 patients with dilated, hypertrophic, or other cardiomyopathies; co-morbidities were registered.

Main Results:

  • Overall diagnostic accuracy for cardiomyopathy was 86.6%, with no significant trend over time.
  • Echocardiography use was high (99.7%), with no increase in diagnostic tool utilization during the study period.
  • No significant differences in co-morbidities were observed over the 20-year study period.

Conclusions:

  • The high diagnostic accuracy and consistent use of echocardiography support that the increase in cardiomyopathy diagnoses is real.
  • The findings strengthen epidemiological evidence suggesting an actual increase in cardiomyopathy occurrence.
  • The study indicates a genuine rise in cardiomyopathy cases, independent of diagnostic advancements or coding changes.
Abstract

Related Concept Videos